Press Releases

Sunshine Heart to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015

Posted on

EDEN PRAIRIE, Minn., Aug. 6, 2015 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Executive Officer, Dave Rosa, is scheduled to present at the 35th Annual Canaccord Genuity Growth Conference in Boston, MA on August 13th at 8:00 AM ET. About the C-Pulse® Heart Assist System The C-Pulse Heart Assist System, or […]

Read More

Sunshine Heart Announces Second Quarter 2015 Results and Provides Corporate Update

Posted on

EDEN PRAIRIE, Minn., Aug. 4, 2015 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the second quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing […]

Read More

Sunshine Heart Provides Update on Fully Implantable Circulatory Support System

Posted on

EDEN PRAIRIE, Minn., July 30, 2015 (GLOBE NEWSWIRE) — Sunshine Heart (NASDAQ:SSH) announced today an update on its next generation, fully implantable version of the Company’s flagship C-Pulse® technology. Sunshine Heart is pleased to report that it will commence a first-in-human study using the novel transcutaneous energy transmission (TET) system and a new smaller implantable […]

Read More

Sunshine Heart to Release Second Quarter 2015 Results on August 4, 2015

Posted on

EDEN PRAIRIE, Minn., July 28, 2015 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its second quarter 2015 results will be released on Tuesday, August 4, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will […]

Read More

Sunshine Heart Provides Update on COUNTER HF(TM) US Pivotal Study for C-Pulse(R) Heart Assist System

Posted on

EDEN PRAIRIE, Minn., July 23, 2015 (GLOBE NEWSWIRE) — Sunshine Heart, Inc. (NASDAQ:SSH) announced today an update on its COUNTER HF™ US pivotal study for the C-Pulse Heart Assist System. COUNTER HF is a prospective, randomized, multi-center, controlled study evaluating the safety and efficacy of the C-Pulse system for the treatment of NYHA Class III […]

Read More